0001209191-18-054892.txt : 20181012
0001209191-18-054892.hdr.sgml : 20181012
20181012163620
ACCESSION NUMBER: 0001209191-18-054892
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181010
FILED AS OF DATE: 20181012
DATE AS OF CHANGE: 20181012
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Harford Simon N.R.
CENTRAL INDEX KEY: 0001443705
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33451
FILM NUMBER: 181120600
MAIL ADDRESS:
STREET 1: AVON PRODUCTS, INC.
STREET 2: 1345 AVENUE OF THE AMERICAS
CITY: NEW YORK
STATE: NY
ZIP: 10105
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ALBIREO PHARMA, INC.
CENTRAL INDEX KEY: 0001322505
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10 POST OFFICE SQUARE
STREET 2: SUITE 502 SOUTH
CITY: BOSTON
STATE: MA
ZIP: 02109
BUSINESS PHONE: 857-415-4774
MAIL ADDRESS:
STREET 1: 10 POST OFFICE SQUARE
STREET 2: SUITE 502 SOUTH
CITY: BOSTON
STATE: MA
ZIP: 02109
FORMER COMPANY:
FORMER CONFORMED NAME: Biodel Inc
DATE OF NAME CHANGE: 20050331
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-10-10
0
0001322505
ALBIREO PHARMA, INC.
ALBO
0001443705
Harford Simon N.R.
C/O ALBIREO PHARMA, INC.
10 POST OFFICE SQUARE, SUITE 502 SOUTH
BOSTON
MA
02109
0
1
0
0
CFO and Treasurer
Common Stock
2018-10-10
4
A
0
5000
0.00
A
5000
D
Stock Option (right to buy)
27.98
2018-10-10
4
A
0
37500
0.00
A
2028-10-09
Common Stock
37500
37500
D
Each restricted stock unit ("RSU") represents the right to receive one share of common stock upon vesting. The RSUs vest as to 25% of the shares on October 10, 2019 with the remainder vesting in equal installments on the last day of 12 consecutive calendar quarters beginning on January 10, 2020 and ending on October 10, 2022.
This option vests as to 25% of the shares on October 10, 2019 with the remainder vesting in equal installments on the last day of 12 consecutive calendar quarters beginning on January 10, 2020 and ending on October 10, 2022.
/s/ Jason Duncan, Attorney-in-fact
2018-10-12